Living drugs that reprogram patients’ immune cells show early promise against hard-to-treat brain tumors
NCS — For many years, a analysis of glioblastoma – an aggressive, hard-to-treat most cancers within the brain – has been a loss of life sentence for sufferers. Only 3%…